Merge Labs secured a $252 million seed round led by OpenAI, valuing the BCI startup at $850 million.
The AMW Read
The $252M seed round and $850M valuation for a BCI startup led by OpenAI introduces a new top-tier entrant in the biological integration layer, signaling a major structural shift toward neuro-AI interfaces.
NoveltySignificance
Healthcare & Bio · Player MapCapital Cycles
Merge Labs secured a $252 million seed round led by OpenAI, valuing the BCI startup at $850 million. Unlike surgical competitors, Merge uses non-invasive ultrasound to bridge human cognition with AI safely. This signals a systemic shift toward an AI Operating System for the Brain, moving from external software to direct biological integration. OpenAI’s lead suggests high-bandwidth neural interfaces will become the primary layer for interacting with AGI in the near future.
